Biotest Aktiengesellschaft (BIO) — Capital Reinvestment Ratio

Latest as of December 2023: 0.50x

Biotest Aktiengesellschaft (BIO) has a Capital Reinvestment Ratio of 0.50x as of December 2023, meaning it reinvests 0% of its operating cash flow (€67.40 Million) in capital expenditures (€33.40 Million). See Biotest Aktiengesellschaft free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.50x
Capex / Operating Cash Flow

Operating Cash Flow

€67.40 Million
EUR

Capital Expenditures

€33.40 Million
EUR

Data as of

Dec 2023
Most recent filing

Biotest Aktiengesellschaft Capital Reinvestment Ratio (2002–2024)

This chart tracks Biotest Aktiengesellschaft's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for Biotest Aktiengesellschaft (2002–2024)

Year-by-year Capital Reinvestment Ratio for Biotest Aktiengesellschaft from 2002 to 2024. For live market cap and broader valuation context, see Biotest Aktiengesellschaft (BIO) total market value.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.47x €60.90 Million €28.70 Million ▼ -12.2%
2021 0.54x €33.90 Million €18.20 Million ▼ -82.7%
2017 3.10x €34.30 Million €106.50 Million ▲ +42.2%
2016 2.18x €65.90 Million €143.90 Million ▼ -17.4%
2015 2.64x €38.10 Million €100.70 Million ▲ +166.0%
2012 0.99x €34.73 Million €34.51 Million ▲ +168.8%
2011 0.37x €72.28 Million €26.72 Million ▼ -2.1%
2010 0.38x €77.83 Million €29.37 Million ▼ -70.2%
2009 1.27x €31.68 Million €40.17 Million ▲ +19.7%
2008 1.06x €34.49 Million €36.54 Million ▲ +43.9%
2004 0.74x €25.29 Million €18.62 Million ▼ -40.7%
2003 1.24x €16.52 Million €20.51 Million ▼ -90.1%
2002 12.52x €2.46 Million €30.80 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow